Cytotoxin-associated gene a-negative strains of helicobacter pylori as a potential risk factor of pancreatic cancer a meta-analysis based on nested case-control studies

Pancreas

Volumn 44, Issue 8, 2015, Pages 1340-1344

  Chen, Xin Zu ^a,b   Wang, Rui ^a   Chen, Hai Ning ^a   Hu, Jian Kun ^a  

^a SICHUAN UNIVERSITY   (China)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Cytotoxin associated gene A; Enzyme linked immunosorbent assay; Etiology; Helicobacter pylori; Pancreatic cancer; Virulent strain

Indexed keywords

CAGA PROTEIN; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; CAGA PROTEIN, HELICOBACTER PYLORI;

ARTICLE; BACTERIAL STRAIN; CANCER RISK; CASE CONTROL STUDY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; NONHUMAN; PANCREAS CANCER; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SYSTEMATIC REVIEW; COMPLICATION; HOST PATHOGEN INTERACTION; METABOLISM; MICROBIOLOGY; ODDS RATIO; PANCREAS TUMOR; PHYSIOLOGY; RISK ASSESSMENT;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CASE-CONTROL STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; HUMANS; ODDS RATIO; PANCREATIC NEOPLASMS; RISK ASSESSMENT; RISK FACTORS;

EID: 84944413704     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0000000000000414     Document Type: Article

References (21)

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr. Accessed September 16, 2014.
2. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52:6735-6740.
3. Franceschi F, Tortora A, Gasbarrini G, et al. Helicobacter pylori and extragastric diseases. Helicobacter. 2014;19:52-58.
4. Franceschi F, Zuccalà G, Roccarina D, et al. Clinical effects of Helicobacter pylori outside the stomach. Nat Rev Gastroenterol Hepatol. 2014;11:234-242.
5. Risch HA, Yu H, Lu L, et al. ABO blood group, Helicobacter pylori seropositivity, and risk of pancreatic cancer: a case-control study. J Natl Cancer Inst. 2010;102:502-505.
6. Trikudanathan G, Philip A, Dasanu CA, et al. Association between Helicobacter pylori infection and pancreatic cancer. A cumulative meta-analysis. JOP. 2011;12:26-31.
7. Xiao M, Wang Y, Gao Y. Association between Helicobacter pylori infection and pancreatic cancer development: a meta-analysis. PLoS One. 2013;8:e75559.
8. Wang Y, Zhang FC, Wang YJ. Helicobacter pylori and pancreatic cancer risk: a meta-analysis based on 2, 049 cases and 2, 861 controls. Asian Pac J Cancer Prev. 2014;15:4449-4454.
9. Stolzenberg-Solomon RZ, Blaser MJ, Limburg PJ, et al. Helicobacter pylori seropositivity as a risk factor for pancreatic cancer. J Natl Cancer Inst. 2001;93:937-941.
10. Lindkvist B, Johansen D, Borgström A, et al. A prospective study of Helicobacter pylori in relation to the risk for pancreatic cancer. BMC Cancer. 2008;8:321.
11. de Martel C, Llosa AE, Friedman GD, et al. Helicobacter pylori infection and development of pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2008;17:1188-1194.
12. Risch HA, Lu L, Kidd MS, et al. Helicobacter pylori seropositivities and risk of pancreatic carcinoma. Cancer Epidemiol Biomarkers Prev. 2014;23:172-178.
13. Kosunen TU, Pukkala E, Seppälä K, et al. The effect of eradication therapy for Helicobacter infection on the incidence of gastric and other cancers. Helicobacter. 2004;9:534.
14. Raderer M, Wrba F, Kornek G, et al. Association between Helicobacter pylori infection and pancreatic cancer. Oncology. 1998;55:16-19.
15. Wadström T, Fryzek JP, Demirjian S, et al. Antibodies to Helicobacter bilis in patients with pancreatic carcinoma. Helicobacter. 2004;9:538-539.
16. Shimoyama T, Takahashi R, Abe D, et al. Serological analysis of Helicobacter hepaticus infection in patients with biliary and pancreatic diseases. J Gastroenterol Hepatol. 2010;25:S86-S89.
17. Gawin A, Wex T, Ławniczak M, et al. Helicobacter pylori infection in pancreatic cancer. Pol Merkur Lekarski. 2012;32:103-107.
18. Yu G, Murphy G, Michel A, et al. Seropositivity to Helicobacter pylori and risk ofpancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2013;22: 2416-2419.
19. Ai F, Hua X, Liu Y, et al. Preliminary study of pancreatic cancer associated with Helicobacter pylori infection. Cell Biochem Biophys. 2015; 71:397-400.
20. Hsu WY, Lin CH, Lin CC, et al. The relationship between Helicobacter pylori and cancer risk. Eur J Intern Med. 2014;25:235-240.
21. Kosunen TU, Pukkala E, Sarna S, et al. Gastric cancers in Finnish patients after cure of Helicobacter pylori infection: a cohort study. Int J Cancer. 2011;128:433-439.